Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 1;30(9):8092-8110.
doi: 10.3390/curroncol30090587.

The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer

Affiliations
Review

The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer

Kazuyuki Numakura et al. Curr Oncol. .

Abstract

A recent approach to radiotherapy for prostate cancer is the administration of high doses of radiation to the prostate while minimizing the risk of side effects. Thus, image-guided radiotherapy utilizes advanced imaging techniques and is a feasible strategy for increasing the radiation dose. New radioactive particles are another approach to achieving high doses and safe procedures. Prostate brachytherapy is currently considered as a combination therapy. Spacers are useful to protect adjacent organs, specifically the rectum, from excessive radiation exposure.

Keywords: brachytherapy; hydrogel spacer; image-guided radiation therapy; intensity-modulated radiation therapy; metastasis direct therapy; prostate cancer; radiation therapy; stereotactic body radiation therapy; volumetric modulated arc therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the study design; data collection, analyses, or interpretation; writing of the manuscript; or decision to publish the results.

Figures

Figure 1
Figure 1
A perspective view of radiation therapy for patients with localized prostate cancer. BT, brachytherapy: EB, external beam radiation therapy; ADT, androgen deprivation therapy; 3D-CRT, three-dimensional conformal radiation therapy: IMRT, intensity modulated radiation therapy; SBRI, stereotache body radiation therapy.

Similar articles

Cited by

References

    1. Yan M., Gouveia A.G., Cury F.L., Moideen N., Bratti V.F., Patrocinio H., Berlin A., Mendez L.C., Moraes F.Y. Practical considerations for prostate hypofractionation in the developing world. Nat. Rev. Urol. 2021;18:669–685. doi: 10.1038/s41585-021-00498-6. - DOI - PMC - PubMed
    1. Wallis C.J.D., Saskin R., Choo R., Herschorn S., Kodama R.T., Satkunasivam R., Shah P.S., Danjoux C., Nam R.K. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur. Urol. 2016;70:21–30. doi: 10.1016/j.eururo.2015.11.010. - DOI - PubMed
    1. Gillessen S., Bossi A., Davis I.D., de Bono J., Fizazi K., James N.D., Mottet N., Shore N., Small E., Smith M., et al. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. Eur. Urol. 2023;83:267–293. doi: 10.1016/j.eururo.2022.11.002. - DOI - PMC - PubMed
    1. Hamdy F.C., Donovan J.L., Lane J.A., Mason M., Metcalfe C., Holding P., Davis M., Peters T.J., Turner E.L., Martin R.M., et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N. Engl. J. Med. 2016;375:1415–1424. doi: 10.1056/NEJMoa1606220. - DOI - PubMed
    1. Donovan J.L., Hamdy F.C., Lane J.A., Mason M., Metcalfe C., Walsh E., Blazeby J.M., Peters T.J., Holding P., Bonnington S., et al. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N. Engl. J. Med. 2016;375:1425–1437. doi: 10.1056/NEJMoa1606221. - DOI - PMC - PubMed

Publication types